Grant of Options - Director/PDMR Shareholding

RNS Number : 7510J

Evgen Pharma PLC

14 December 2022

 

Evgen Pharma plc

("Evgen" or the "Company")

Grant of Options

Evgen Pharma plc (AIM: EVG), a clinical stage drug development company  developing sulforaphane-based medicines   announces that , on 14 December 2022, certain employees and directors of the Company, including the following Persons Discharging Managerial Responsibility ("PDMR"), were granted nil cost options (the "Options") over a total of 11,122,199 ordinary shares of 0.25 pence each in the Company ("Ordinary Shares"), exercisable, subject to the Options vesting, for a period of up to 10 years from the date of grant and governed by the rules of the Evgen Pharma plc Long Term Incentive Plan ("LTIP").

PDMR	Position	Current Ordinary Shares held	Current Options held	New options granted	% of issued share capital including this award
Dr Huw Jones	CEO	62,500	4,648,890	4,410,727	3.3%
Richard Moulson	CFO	45,454	889,728	1,460,855	0.9%

The Options will vest on the third anniversary of grant based on performance against challenging

strategic corporate objectives over three years (40%), share price growth (30%) and on an elapsed time basis at 3 years (30%).

Following this award there are 21,361,574 options in issue, representing 7.8% of the Company's issued share capital.

Enquiries:

Evgen Pharma   plc Dr Huw Jones, CEO  Richard Moulson, CFO	[phone]
FinnCap (Nominated Advisor and Broker) Geoff Nash / Teddy Whiley (Corporate Finance) Alice Lane/Nigel Birks (ECM)	[phone]
Instinctif Partners Melanie Toyne-Sewell / Rozi Morris / Agnes Stephens / Adam Loudon	[phone] [e-mail]

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Huw Jones
2	Reason for the notification
a)	Position/status	CEO
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Evgen Pharma Plc
b)	Legal Entity Identifier	213800NO3E6TSTQO8K20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options over Ordinary Shares of 0.25 pence each  GB00BSVYN304
b)	Nature of the transaction	Grant of options
c)	Currency	GBP
d)	Price(s) and volume(s)	Price(s)	Volume(s)
		nil	4410727
e)	Aggregated information - Aggregated volume - Price - Aggregated total	As above
f)	Date of the transaction	14 December 2022
g)	Place of the transaction	London Stock Exchange, AIM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Richard Moulson
2	Reason for the notification
a)	Position/status	CFO
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Evgen Pharma Plc
b)	Legal Entity Identifier	213800NO3E6TSTQO8K20
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Options over Ordinary Shares of 0.25 pence each  GB00BSVYN304
b)	Nature of the transaction	Grant of options
c)	Currency	GBP
d)	Price(s) and volume(s)	Price(s)	Volume(s)
		nil	1460855
e)	Aggregated information - Aggregated volume - Price - Aggregated total	As above
f)	Date of the transaction	14 December 2022
g)	Place of the transaction	London Stock Exchange, AIM

 

END

 

 

DSHUSRBRUSUUAAA